Clinical Monitoring of Endothelial Dysfunction for Pregnant Women and in the Perioperative Course

Endothelial Dysfunction Clinical Trial

Official title:

Clinical Monitoring of Endothelial Dysfunction for Pregnant Women and in the Perioperative Course - a Pilot Study

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01311297
• Other study ID #: POPEYE
• Status: Terminated
• Start date: March 29, 2011
• Est. completion date: September 29, 2012

Study information

• Verified date: May 2018
• Source: Charite University, Berlin, Germany
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A single- center prospective observational study. This study evaluates different aspects of endothelial function. It investigates the endothelial leakage with the venous occlusion plethysmography and the flow-mediated vasodilatation by ischaemia reperfusion testing.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 47
• Est. completion date: September 29, 2012
• Est. primary completion date: September 29, 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Offered patient information and written informed consent

• Female patients aged greater than or equal to 18 years:

1. for reduction of a primary ovarian tumour or recidive of an ovarian tumour

2. pregnant patients with:

• clinical normal pregnancy

• pregnancy with weight gain of more than 10 kg

• pregnancy and gestosis

3. healthy volunteers

Exclusion Criteria:

• Persons without the capacity to consent

• Unability of German language use

• Lacking willingness to save and hand out data within the study

• Accommodation in an institution due to an official or judicial order

• (Unclear) history of alcohol or substances disabuse

• Coworker of the Charité

• Advanced disease of the oesophagus or upper respiratory tract

• Operation in the area of the oesophagus or nasopharynx within the last two months

• Neurological or psychiatric disease

• CHF (congestive heart failure) according to (New York Heart Association) classification - NYHA class IV at the beginning of hospital stay

• American Society of Anaesthesiologists (ASA) classification greater than IV

• Renal insufficiency (dependency of haemodialysis)

• Pulmonal oedema in thorax x-ray

• History of intracranial hemorrhage within one year of participation in the study

• Conditions following venous thrombosis within the last three years before study inclusion

• Inflammatory or reflective disease of blood vessels (Raynaud-Syndrome, Vasculitis)

• Inherent connective tissue disease(e.g. Marfan Syndrome)

Related Conditions & MeSH terms

• Endothelial Dysfunction

Locations

Country	Name	City	State
Germany	Department of Anesthesiology and Intensive Care Medicine, Campus Virchow Klinikum, Charité - Universitaetsmedizin	Berlin

Sponsors (1)

Lead Sponsor	Collaborator
Claudia Spies

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Filtration coefficient	Endothelial parameter from the examination with venous occlusion plethysmography.	perioperatively up to the fifth postoperative day in patients undergoing surgery
Primary	Filtration coefficient	Endothelial parameter from the examination with venous occlusion plethysmography.	up to one hour single measurement in pregnant woman
Secondary	All patients: Hemodynamic parameters		perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	All patients: Markers of endothelial dysfunction (ICAM-1, E-Selectin, vWF)		perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	All patients: Endothelial flow-mediated vasodilatation		perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	Perioperative patients: Blood loss		perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	Perioperative patients: Parameter of monitored sedation (BIS - Monitoring)		during the operation
Secondary	Perioperative patients: Incidence and impact of organ dysfunctions		perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	Perioperative patients: Pain	Patient self-assessed postoperative pain levels during rest using an unmarked zero to one hundred mm visual analog scale (VAS)	perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	Perioperative patients: Body weight		perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	Perioperative patients: Satisfaction of the patients, surgeon and anesthesiologist		on the day of surgery
Secondary	Perioperative patients: Duration until clinical discharge criteria were satisfied	Postanesthesia Discharge Scoring System (PADS) for Determining Home-Readiness	perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	Perioperative patients: Intensive care unit average length of stay; hospital average length of stay		perioperatively up to the fifth postoperative day in patients undergoing surgery
Secondary	Perioperative patients: Quality of life	Descriptive system of health-related quality of life states consisting of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of which can take one of three responses. The responses record three levels of severity (no problems/some or moderate problems/extreme problems) within a particular EQ-5D dimension.	perioperatively up to hospital discharge in patients undergoing surgery, an expexcted average of two weeks
Secondary	Pregnant patients: History data of the pregnancy, parameter of Gestosis	Gestosis: toxemia of pregnancy	up to one hour single measurement in pregnant woman
Secondary	All patients: Immunological Markers	Differences in selected immunologic parameters among others IL-6, IL-10	perioperatively up to the fifth postoperative day in patients undergoing surgery